Manifestations of X‐linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers
European Journal of Neurology · 2024
DOI: 10.1111/ene.16283 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Antri Savvidou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Pyruvate Dehydrogenase (Lipoamide), Pyruvate Dehydrogenase Complex Deficiency Disease, Heterozygote. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anna-Lisa och Bror Björnssons Stiftelse, Stiftelsen Samariten, Linnéa och Josef Carlssons Stiftelse.
Abstract (Originalsprache)
Background and purpose Pyruvate dehydrogenase complex deficiency is in up to 90% caused by pathogenic variants in the X‐linked PDHA1 gene. We aimed to investigate female relatives of index patients with PDHA1 ‐related disease to (i) describe the prevalence of female PDHA1 carriers, (ii) determine whether they had symptoms and signs, and (iii) delineate the associated phenotype.
Methods
In a national population‐based study, we identified 37 patients with pathogenic variants in PDHA1 . Sanger sequencing for the presence of the pathogenic variant was performed in their mothers and female relatives. The identified female carriers were clinically assessed, and their medical records were reviewed.
Results
The proportion carrying a de novo variant was 86%. We identified seven female PDHA1 carriers from five families. Five of them exhibited clinical features of the disease and were previously undiagnosed; all had signs of peripheral axonal neuropathy, four presented with strokelike episodes including two with Leigh‐like lesions, and three had facial stigmata.
Conclusions
PDHA1 ‐related disease is underrecognized in heterozygous female carriers. Peripheral axonal neuropathy, strokelike and Leigh‐like changes, and facial dysmorphism should raise suspicion of the disorder. Genetic analysis and clinical examination of potential female carriers are important for genetic counseling and have implications for treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Pediatrics, Queen Silvia Children's Hospital, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Section of Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Department of Pediatrics, Ryhov Hospital, Jönköping, Sweden.
ORCID-Profile: Antri Savvidou
Förderung
- Anna-Lisa och Bror Björnssons Stiftelse
- Stiftelsen Samariten
- Linnéa och Josef Carlssons Stiftelse
Zitieren
APA
Savvidou, A., Sofou, K., Eklund, E. A., Aronsson, J., & Darin, N. (2024). Manifestations of X‐linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers. European Journal of Neurology. https://doi.org/10.1111/ene.16283
Vancouver
Savvidou A, Sofou K, Eklund EA, Aronsson J, Darin N. Manifestations of X‐linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers. European Journal of Neurology. 2024. doi:10.1111/ene.16283
BibTeX
@article{Savvidou2024,
author = {Savvidou, Antri and Sofou, Kalliopi and Eklund, Erik A and Aronsson, Johan and Darin, Niklas},
title = {Manifestations of X‐linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16283}
}
EUVIMED